CTA, MRA, Angiography, Venography, IVUS, and Radiation Safety

8.1Principles of modality selection

Modality selection aligns with the intended clinical decision rather than scanner availability. In peripheral artery disease (PAD), imaging is reserved for patients in whom revascularization is contemplated, symptoms progress despite guideline-directed therapy, or unresolved diagnostic questions remain. Routine anatomic imaging is not indicated for asymptomatic PAD or stable intermittent claudication responding to medical and exercise therapy ESVS 2024 · ESC 2017. When revascularization is planned, advanced anatomic imaging is interpreted in the context of symptoms, wounds, and physiologic testing ACC/AHA PAD 2024.

For aortic disease, diagnosis and surveillance rely on consistent anatomic landmarks, acquisition techniques, and reporting across computed tomography (CT), magnetic resonance imaging (MRI), and echocardiography to enable reliable interpretation of interval growth and post-intervention change ACC/AHA Aortic Disease 2022.

8.2Diagnostic modalities and indications

Each imaging modality occupies a defined role in the diagnostic and therapeutic pathway:

• Duplex ultrasound: Serves as the first-line anatomic-hemodynamic test for diagnosing PAD and localizing lesions when local laboratory quality is reliable ACR Appropriateness Criteria 2022. It is the standard initial modality for abdominal aortic aneurysm (AAA) screening, demonstrating 94% to 100% sensitivity and 98% to 100% specificity for AAA detection, and conferring a population-level mortality benefit in men aged 65 to 74 years USPSTF 2019 · MASS (2002). USPSTF 2019 recommends one-time screening ultrasonography for AAA in men aged 65 to 75 who have ever smoked (Grade B) and selectively offering screening to men 65 to 75 who have never smoked (Grade C). Limitations include body habitus, bowel gas, severe arterial calcification, and multilevel disease.
• Computed tomography angiography (CTA): Functions as the primary modality for broad anatomic mapping and revascularization planning. It defines inflow, outflow, access vessels, prior interventions, and calcification ACR Appropriateness Criteria 2022. Efficacy is degraded by severe calcification, while risk profiles include iodinated contrast and ionizing radiation exposure.
• Magnetic resonance angiography (MRA): Provides a zero-ionizing-radiation alternative for lower-extremity vascular imaging, particularly favored in young patients, those requiring repeated imaging, or those with renal impairment ACR Appropriateness Criteria 2022. Image quality is limited by stent artifact, severe calcification, motion, and claustrophobia. Safety relies on strict magnetic resonance environment screening for implants and devices ACR MR Safety Manual · 2024.
• Catheter angiography (DSA) and venography: Reserved primarily for therapeutic encounters in which endovascular intervention is planned or when noninvasive imaging is inconclusive ACR Appropriateness Criteria 2022 · CREST (2010). Diagnostic-only angiography is unusual and carries procedural risk, contrast burden, and operator-dependent radiation exposure.
• Intravascular ultrasound (IVUS): Acts as an intraprocedural adjunct to clarify ambiguous angiographic findings (such as true versus false lumen, plaque burden, or dissection extent), size endografts in EVAR and TEVAR, and assess post-stent apposition Secemsky 2024 · AUC Peripheral Vascular Ultrasound 2012. It does not replace noninvasive cross-sectional imaging for global preoperative characterization.

8.3Imaging pathways and interpretation thresholds

Thoracic aortic CTA or MRA requires standardized inner-edge-to-inner-edge ECG-synchronized measurements, using outer-edge measurements when wall abnormalities are present ACC/AHA Aortic Disease 2022. Late post-EVAR imaging is indicated to identify device-related failure or anatomy requiring reintervention, guided by 15-year outcomes demonstrating late rupture and reintervention risks EVAR-1 (2016). Baseline contrast CTA is obtained within the first month after EVAR; if no endoleak or sac enlargement is present, surveillance moves to color duplex ultrasound (with or without contrast CT) at 12 months and annually thereafter, whereas a detected endoleak or sac growth shortens imaging to roughly 6-month intervals and prompts review for reintervention SVS 2018.

Standardized thresholds govern disease grading and intervention triggers. In lower-extremity arterial duplex, peak systolic velocity (PSV) and peak systolic velocity ratios (PSVR) assign stenosis severity, though heavy calcification and multilevel disease can elevate velocities independently of true critical stenosis AUC Peripheral Vascular Ultrasound 2012.

8.4Contrast and magnetic resonance safety

Iodinated contrast administration requires pre-procedural risk assessment, hydration planning, and acute reaction-response systems encompassing allergic-like and physiologic reactions ACR Contrast Manual · 2025. Patients with a prior allergic-like contrast reaction receive corticosteroid plus antihistamine premedication before repeat iodinated contrast exposure. The standard elective regimen is prednisone 50 mg PO at 13, 7, and 1 hour before contrast plus diphenhydramine 50 mg IV, IM, or PO 1 hour before; methylprednisolone 32 mg PO 12 and 2 hours before contrast is an equivalent alternative. When contrast cannot wait but at least 4 to 5 hours remain, an accelerated intravenous course substitutes hydrocortisone 200 mg IV or methylprednisolone 40 mg IV every 4 hours until contrast, with diphenhydramine 50 mg IV 1 hour before. Post-contrast acute kidney injury (AKI) is monitored using Kidney Disease: Improving Global Outcomes (KDIGO) Stage 1 criteria, which trigger early review of volume status, hemodynamics, and nephrotoxic medications.

Magnetic resonance safety operates as an institutional workflow rather than a point-of-care checklist. Safe MRA requires zone-based environment control, structured screening for implants and devices, staff role definitions, and management of static magnetic field, gradient, and radiofrequency hazards ACR MR Safety Manual · 2024.

Gadolinium-based agents carry a risk of nephrogenic systemic fibrosis in advanced renal impairment (eGFR < 30 mL/min/1.73 m^2); group II (macrocyclic) agents are preferred and given at the lowest dose adequate for diagnosis ACR Contrast Manual · 2025 · ACR MR Safety Manual · 2024 · KDIGO 2012. In pregnancy and lactation, iodinated and gadolinium-based contrast are given with standard obstetric caution, only when the diagnostic question cannot be answered without them.

8.5Radiation stewardship

CTA and fluoroscopically guided interventions (angiography, venography) deliver moderate-to-high relative radiation doses. Operators employ the As Low As Reasonably Achievable (ALARA) principle by tailoring protocols to patient size, using non-ionizing alternatives (such as ultrasound or MRA) when appropriate, and documenting exposure parameters including dose-length product, dose-area product, and fluoroscopy time ACR Appropriateness Criteria 2022. Radiation protection, achievable dose limits, and occupational monitoring follow established international frameworks and institutional diagnostic reference levels ACR Radiation Safety · ICRP 103 · 2007.

8.6Areas of controversy

The routine application of adjunctive IVUS across peripheral and aortic endovascular interventions is debated. While it offers superior intraoperative sizing and apposition confirmation, it adds procedural time and cost, and its diagnostic benefit remains operator- and anatomy-dependent Secemsky 2024 · AUC Peripheral Vascular Ultrasound 2012.

Duplex velocity thresholds for lower-extremity stenosis grading are not uniformly established. Heavy calcification and tandem lesions alter peak systolic velocity independently of true critical stenosis, requiring individual laboratory validation rather than unadjusted reliance on society-published numeric cutoffs AUC Peripheral Vascular Ultrasound 2012. Furthermore, detailed reporting formats and specific post-imaging surveillance intervals lack uniform standardization and remain heavily dependent on local protocols and variations in disease type. Diameter-based AAA surveillance is better standardized than this implies: SVS 2018 sets duplex ultrasound intervals of every 3 years for aneurysms of 3.0 to 3.9 cm, every 12 months for 4.0 to 4.9 cm, and every 6 months for 5.0 to 5.4 cm, and ESVS 2019 gives comparable diameter-based intervals ESVS 2019 · SVS 2018.